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Abstract 
Small ruminant lentivirus (SRLV) infection causes losses in the small ruminant industry due to reduced animal produc‑
tion and increased replacement rates. Infection of wild ruminants in close contact with infected domestic animals 
has been proposed to play a role in SRLV epidemiology, but studies are limited and mostly involve hybrids between 
wild and domestic animals. In this study, SRLV seropositive red deer, roe deer and mouflon were detected through 
modified ELISA tests, but virus was not successfully amplified using a set of different PCRs. Apparent restriction of SRLV 
infection in cervids was not related to the presence of neutralizing antibodies. In vitro cultured skin fibroblastic cells 
from red deer and fallow deer were permissive to the SRLV entry and integration, but produced low quantities of virus. 
SRLV got rapidly adapted in vitro to blood‑derived macrophages and skin fibroblastic cells from red deer but not from 
fallow deer. Thus, although direct detection of virus was not successfully achieved in vivo, these findings show the 
potential susceptibility of wild ruminants to SRLV infection in the case of red deer and, on the other hand, an in vivo 
SRLV restriction in fallow deer. Altogether these results may highlight the importance of surveilling and controlling 
SRLV infection in domestic as well as in wild ruminants sharing pasture areas, and may provide new natural tools to 
control SRLV spread in sheep and goats.
© 2016 Sanjosé et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
In the last century we have witnessed the emergence 
of acquired immunodeficiency syndrome, multidrug-
resistant tuberculosis and tick-borne related diseases as 
a result of the interactions between humans and zoonotic 
pathogens in a pathway including wildlife and domestic 
animals [1].
Small ruminant lentiviruses (SRLV) infection is present 
in sheep and goats from Europe [2], America [3–5], Aus-
tralia [6], Africa [7] and Asia [8, 9]. Economic impact of 
SRLV infection, highly dependent on environmental fac-
tors, breed/individual susceptibility, production system, 
farming practices and age of culling is often underesti-
mated and still under study [10]. The premature removal 
of infected animals and the consequent increased 
replacement rate is a major consequence of SRLV infec-
tion. SRLV infected sheep have shown decreased fertility 
and number of lambs per birth, as well as a reduction of 
birth weight and weight gain from birth to weaning [11, 
12]. Animals with advanced disease present a signifi-
cantly reduced body weight at slaughter, and their carcass 
may not qualify for human consumption [13]. The most 
obvious positive result observed following the eradica-
tion of SRLV infections in goats’ herds is the disappear-
ance of clinical cases of carpal arthritis and the improved 
health of the flocks [10]. This combined with the elimi-
nation of a viral infection showing a negative impact on 
milk production [14–16] may well explain the financial 
success of a combined eradication campaign comprising 
SRLV, such as “The Norwegian Healthier Goats program” 
[17].
SRLV are able to cross inter-species barrier thereby 
infecting sheep and goats through horizontal and lac-
togenic routes [10]. Since the first descriptions of natu-
ral transmissions of Visna Maedi virus (VMV) to goats, 
or Caprine arthritis encephalitis virus (CAEV) to sheep 
[18], many research groups have reported cross-species 
transmission in different countries [19–21]. Recently, 
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new genotypes, subtypes and recombinant SRLV viruses 
have been described widening significantly their genetic 
and antigenic heterogeneity, likely conferring them a 
wider spectrum of cell and host tropism. Env and LTR 
genomic regions have been related to cell tropism by 
modifying the receptor usage [22] or by enhancing the 
promoter activity depending on the transcription fac-
tors present in a particular cell type, respectively [23]. 
Typically, the virus exists in the infected host as a con-
tinuum of related but divergent genetic variants called 
quasispecies that compartmentalize in different tissues 
or body fluids [24, 25] potentially favoring cross-species 
transmission.
The transmission of infectious agents from reservoir 
animal populations, often from domesticated species to 
wildlife in shared pastures or breeding areas (spill-over), 
may lead to the emergence of a range of infectious dis-
eases in the wildlife. Spill-over is particularly important 
for endangered species and may also occur from wild-
life to domestic animals (spill-back) affecting animal 
production [1]. A well-known example of adaptation to 
a new host is the human immunodeficiency virus (HIV) 
that successfully overcame the intrinsic restriction fac-
tors constitutive of the species-specific barrier, to suc-
cessfully infect humans [26]. HIV-2 is a human adapted 
variant of the simian immunodeficiency virus (SIV) from 
Sootey mangabeys (Cercocebus atys) [27], and HIV-1 may 
be similarly derived from a chimpanzee (Pan troglodytes) 
SIV [28]. There are different examples of inter-species 
transmission of lentiviruses displaying more attenuated/
virulent phenotype in the new host. In general, SIV cause 
no observable disease in their natural hosts but may 
become severe pathogens in novel host species [29]. In 
the case of BIV, which is non-pathogenic for Bos taurus, 
the transmission to Bos javanicus resulted in lethal Jem-
brana disease [30].
During the last decades many species of wild rumi-
nants have been reintroduced and others have expanded 
their population across Europe, both in density and 
geographical range. Transmission of pathogens from 
or to domestic ruminants poses serious problems since 
infected wildlife and domestic ruminants may rep-
resent a pathogen reservoir to each other [31]. So far, 
SRLV have been found in Alpine ibexes (Capra ibex) 
from French Alps in contact with domestic goats as well 
as in hybrids derived from this contact, both of which 
showed proviral sequences related to CAEV present 
in local domestic goats [32]. In Rocky Mountain goats 
(Oreamnos americanus), CAEV is able to be transmit-
ted by lactogenic and horizontal routes causing a severe 
multisystemic disease involving lungs, central nerv-
ous system and joints [33]. Mouflon (Ovis aries musi-
mon) and domestic sheep hybrids are also susceptible to 
CAEV infection [34]; however, among a 101 wild mou-
flon population from Spain, none showed positive serol-
ogy against VMV [35]. Similar results were obtained 
when analyzing sera from red deer in California [36–
38], suggesting lack of susceptibility of these wild rumi-
nants to SRLV.
This study aims at providing further evidence of the 
potential susceptibility of wild ruminants to SRLV infec-
tion. We present serological evidence that different wild 
ruminants may have mounted an antibody response to 
SRLV. Additionally, we explored the susceptibility of red- 
and fallow deer cells to different SRLV strains for entry, 
integration, replication and production of infectious viral 
particles.
Materials and methods
Animals and samples
259 red deer (Cervus elaphus), 36 roe deer (Capreolus 
capreolus), 40 fallow deer (Dama dama) and 16 mouflon 
(Ovis aries musimon) from different origins as speci-
fied in Figure 1, were sampled to obtain whole blood in 
EDTA-3  K as anticoagulant. Deer were from zoos (4%), 
national parks (4%), production farms (61%) and hunt-
ing campaigns (31%). Roe deer were all from hunts, fal-
low deer from zoos (37.5%) and national parks (62.5%) 
and mouflon were from zoos (62.5%) or national parks 
(37.5%).
Plasma was obtained and stored at −20  °C for sero-
logical determinations and buffy coat for PCR analyses. 
Peripheral blood leucocytes (PBLs) were isolated from 
buffy coat samples by density gradient centrifugation and 
resuspended in PBS for DNA extraction using QIAamp® 
DNA Blood Mini Kit (Qiagen).
Serological analysis
Plasma samples were analyzed for SRLV antibodies by 
four different ELISA methods. Commercial ELISAs for 
detection of SRLV antibodies were slightly modified in 
order to detect IgG from wild ruminant species. This was 
achieved in a first round, by using protein Pierce Purified 
Recomb® Protein G Peroxidase conjugated (Recombinant 
Protein G, Pierce) or secondly, with a secondary anti-
body able to cross-react with a wide range of ruminant 
species, including red deer and fallow deer (EG5, Inge-
nasa). ELISA plates used included commercial Chekit 
(AG-CHEKIT CAEV/MVV kit, IDEXX Switzerland), 
ELITEST (Elitest-MVV Hyphen-Biomed, France) and a 
previously described home-made ELISA that is based on 
coating with single synthetic peptides alone or in combi-
nation [39]. Procedures were carried out following manu-
facturer’s instructions with the exception of the conjugate 
antibody which, as mentioned, was substituted by a sec-
ondary antibody able to react with wild species’ IgG.
Page 3 of 12Sanjosé et al. Vet Res  (2016) 47:1 
PCR
DNA samples from fifteen seropositive and four seroneg-
ative animals were subjected to amplification by described 
PCRs for SRLV and BIV detection (Table  1). Thermal 
amplification protocols were adapted to annealing tem-
perature of each primer pair and results were analyzed in 
1% agarose gels. Bands of the expected molecular weight 
were cut and purified using ATP Gel/PCR extraction kit 
(ATP Biotech Inc.). Purified products were cloned into 
pGEMT-easy vector (Promega) following manufacturer’s 
instructions and sequenced using M13 primers.
Cells and SRLV in vitro infection
Red deer (DSF) and fallow deer (FSF) skin fibroblasts 
were obtained from skin biopsies, isolated by trypsin dis-
ruption and cultured in DMEM medium supplemented 
with 10% foetal bovine serum (FBS), 1% l-glutamine and 
1% antibiotic/antimycotic mix (Sigma-Aldrich). Previ-
ously obtained ovine skin fibroblasts (OSF) or goat syno-
vial membrane cells (GSM) were used as control cells as 
indicated throughout the experiments.
Blood derived macrophages (BDM) from deer and fal-
low deer were also obtained as described [40]. Briefly, 
buffy coat diluted in PBS was loaded onto Ficoll-Paque 
Premium 1.084 (GE Healthcare) gradient to isolate 
peripheral blood mononuclear cells. BDM were obtained 
by adherence and cultured in RPMI 1640 supplemented 
with 1% l-glutamine, 1% non-essential amino acids, 
50 µM β-mercaptoethanol, 1% vitamins, 10 mM sodium 
pyruvate and 10% foetal bovine serum (FBS). Sheep BDM 
were also obtained for comparative purposes. Cultures 
with fibroblast-like cells overgrowth were discarded.
Established cultures were maintained and used in 
experimental infections with Ev1 [41], CAEV-Co [42], A4 
[21] and Ov496 strains of SRLV [19]. In vitro infection 
was carried out at 0.1 and 1 TCID50/cell in DMEM 2% 
medium in the case of Ev1 and 496 strains and with 20 
copies/cell in the case of CAEV-Co and A4 isolates. After 
16 h, cells were washed three times with PBS and resus-
pended in lysis buffer AL (Qiagen) for DNA extraction 
and amplification of viral DNA with described primers 
(Table 1). For confirmatory purposes, DNA from in vitro 
infected fibroblastic cells was subjected to PCR with 
primers Craft-Oslo, A4-SU and CO-SU, for strains EV1, 
496 and A4, CAEV-Co, respectively (Table  1). Ampli-
cons were purified, cloned into pGEMT-easy vector and 
sequenced (StabVida). Additionally, after washing with 
PBS, cultures were maintained 10 days post inoculation 
for RT-activity determinations following manufacturer’s 
instructions for Ev1 and 496 strains (HS-Lenti RT Activ-
ity Kit, Cavidi). Viral quantification (viral RNA copies/
µL) of A4 and CAEV-Co strains in the supernatants was 
Figure 1 Bubble chart of the sampling distribution. Blood samples from red deer, fallow deer, roe deer and mouflon were obtained from 
commercial farms, zoological or national parks or hunting campaigns in different Spanish regions. The bubbles are sized according to the number 
of sampled animals.
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done by qPCR (Qiagen QuantiTec Probe RT-PCR) using 
primers and TaqMan probes g6621 and 614 respectively 
(Table 1).
BDM supernatants were collected at 3, 10 and 14 days and 
the CAEV-Co and A4 viral RNA was quantified by real time 
PCR using specific primers and Taqman probes (Table 1).
Table 1 Primers covering gag, pol, LTR and env regions, were used for the SRLV detection by PCR
Primers able to amplify bovine inmunodeficiency virus were included
PCR assay Primers Sequence 5′–3′ References
Gag nested PCR GAG F1 TGG TGA RKC TAG MTA GAG ACA TGG [64]
GAG F2 CAA ACW GTR GCA ATG CAG CAT GG
POL R1 CAT AGG RGG HGC GGA CGG CAS CA
POL R2 GCG GAC GGC ASC ACA CG
Pol nested PCR P28 CAT GAA GAG GGG ACA AAT CAG CA [18]
P34 TAC ATT GGG TGC CTG GAC ATA A
P32 TAC CTG DGT TGG TCC YWG CCA CT
P33 CTT CCC AVA GTA CCT GDG TTG GTC
P29 GGT GCC TGG ACA TAA AGG GAT TC
P35 GCC ACT CTC CTG RAT GTC CTC T
Gag‑Can nested PCR CAEV F0 AAC TGA AAC TTC GGG GAC GCC TG [5]
CAEV F1 AAG GTA AGT GAC TCT GCT GTA CGC
CAEV F2 TGG TGA GTC TAG ATA GAG ACA TGG
CAEV R0 GTTATCTCGTCCTAATACTTCTACTGG
CAEV R1 TTT TTC TCC TTC TAC TAT TCC YCC
CAEV R2 GGA CGG CAC CAC ACG TAK CCC
MVV F0 AAG TAA GGT AAG AGA GAC ACC TAC TGG
MVV F1 TAG ATA GAG ACA TGG CGA AGC AAG CTC
MVV F2 GAC AGA AGG GAA CTG TCT ATG GGC
MVV R0 GGT GGT GCT TCT GTT ACA ACA TAG G
MVV R1 GGA CGG CAC CAC ACG TGG
MVV R2 CCC CTC CTG YTG TTT CCC TG
BIV nested PCR POL3 ACA ACG GGC CGT GCT TTA CTG [65]; [66]
POL4 CCT CTT CCT CTA TTA CTG CTG C
POL5 GAR AAT CTA TGT AAG TAT CTG GG Unpublished data (Nadin‑Davis)
POL6 CTG TTY CTT ACG TAA CAC CAC T
P09 CAC TGG ACG AGA TGA GGT AGT [67]
P06 TGG TAG TCT GAT AAA TGG CA
P04 CAG GCT CTT AAG GAA ATT GT
P11 CCA TCC TTG TGG TAG AAC ATT
Craft‑Oslo Craft‑Fw TGA CAG AAG GAA ATT GTY TRT GG
Oslo‑Rv GGC ATC ATG GCT AAT ACT TCT AA [68]
LTR PCR LTR‑Fw TGA CAC AGC AAA TGT AAC CGC AAG [69]
LTR‑Rv CCA CGT TGG GCG CCA GCT GCG AGA
CO qPCR 612‑F GAA CTC AGC CAC AAG AGG AAG AA [70]
613‑R CCT GCG GCA GCT ACT ATT GC
614 Probe FAM AACTAGCATAATGACCAAGCCAACGCCTCT BHQ‑1
A4 qPCR Fs7631/Fg6221 ACA AAC TGG ACC ACC ATG CA [21]
Rg6221 CTA GTG TTC CAT TTC CTG TTC TGT TTA
Probe g6221 FAM GGC AAC TGT TCW CAG TGT GTT AAT GYA ACG BHQ‑1
A4‑SU PCR SU5‑1F GTA GAT GTG TAC AAA GAC CAG [21]
SU5‑1R CTG CCT CTA ACA CTT GCT GC
CO‑SU PCR B1‑SU5‑1R TGC CTC TAA CAC ATC CTG CTG TGC [70]
B1‑SU5‑1F GGT GGA ACA TAT GAC AGG AG
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LTR promoter activity
LTR basal activity from strains A4 [21], KV1772 [43], 
Ov496 [19] and CAEV-Co [42] was assayed using a lucif-
erase reporter system. Briefly, DSF, FSF and GSM cells 
(105 in 24-well plates) were transfected with 200  ng of 
each LTR construction using 4 µL of Lipofectamine-LTX 
Reagent and 0.2 µL of PLUS-Reagent (Life Technologies). 
Plasmids pGL4.13 [luc2/SV40] and “empty” p-GL4.10 
[luc2] were used as positive and negative controls, 
respectively. At the same time, 20 ng of pGL4.73 [hRluc/
SV40] Vector (Promega) were cotransfected, so that the 
firefly activity was standardized according to the Renilla 
luciferase activity. After 24  h, cells were harvested with 
Passive Lysis 5X Buffer (Promega), and firefly and renilla 
luciferase activity were measured following manufac-
turer’s instructions. Results were expressed as: Relative 
Luminiscence Units (RLU) firefly luminescence/RLU 
Renilla luminescence.
Entry assay
CAEV (including human alkaline phosphatase, AP) [22] 
virions pseudotyped with ENV proteins from strains Ev1 
[41], CAEV-Co [42], 697 [44], Roccaverano [45] and Seui 
[46] of SRLV, as well as Vesicular Stomatitis virus pro-
tein G (VSV-G) produced in 293-T cells as described [22, 
47] were used to transduce red deer and fallow deer skin 
fibroblasts. Briefly, pseudoviruses were incubated with 
target cells and after 72 h cells were washed three times 
with PBS and endogenous AP activity blocked by heat-
ing at 65 °C 1 h in a humidified chamber. After blocking, 
NCTBI reagent was added to cells for 2–24 h and finally 
reaction was stopped with normal water. Stained cells 
were visualized and counted under light microscopy by 
two experts.
Western blot
Sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS-PAGE) was carried out using Ev1 and 496 
infected DSF, FSF and OSF extracts. For Western blot 
analysis, monoclonal antibodies against p25 (VPM70, 
kindly provided by Dr B. Blacklaws, University of Cam-
bridge, UK) was used undiluted. Anti-mouse IgG peroxi-
dase-conjugated (Pierce) was used as secondary antibody. 
In addition, sera from two experimentally infected sheep 
with SRLV strains from genotype A and B respectively 
were used to reveal protein production. Reactions were 
developed by chemiluminescence (Amersham ECL West-
ern blotting detection reagents; GE Healthcare, Bucking-
hamshire, UK).
Neutralizing antibody (NtAb) assay
Heat inactivated sera from ELISA positive red deer 
(n  =  6) were serially diluted in DMEM 2% FBS in a 
96-well plate and incubated 1:1 (vol/vol) with 100 TCID50 
of strain Ev1. Six wells were used per serum dilution. 
After mixing and incubating overnight at 4  °C, the mix-
ture was added to sheep fibroblasts. After 2  h at 37  °C, 
5% CO2, the supernatant containing the virus and serum 
mixture was removed and after washing DMEM 2% FBS 
was added. Following a 7  day incubation at 37  °C and 
5% CO2 cytopathic effect (CPE, syncitia formation) was 
screened by microscopy. The NtAb titer was defined as 
the reciprocal of the serum dilution in which 50% of the 
culture wells showed no signs of infection.
Results
ELISA
Using the home-made ELISA based on synthetic pep-
tides and protein G as conjugate, SRLV antibodies were 
detected in 14 out of 193 (7%) red deer and one mou-
flon out of 10 analyzed. Using a secondary antibody able 
to react against wild ruminant species (EG5, Ingenasa), 
increased the number of seropositive red deer to 20 out 
of 141 (14%) and, moreover, allowed the detection of 
SRLV antibodies in 3 out of 36 roe deer (8%) and one 
mouflon, but not in fallow deer. Combining results using 
protein G and EG5 conjugates SRLV antibodies were 
detected in 26 out of 259 (10%) red deer, 3 out of 36 roe 
deer and one out of 16 analyzed mouflon.
Single peptide ELISA analyses indicated that peptides 
126M1 and 126M2 were responsible for the seropositiv-
ity in most of the animals (Figure 2).
In order to confirm specificity of these antibody reac-
tions, some sera were also tested for anti-SRLV antibod-
ies using commercial ELISA (Chekit and Elitest). None of 
the animals that were seropositive to the peptide ELISA 
were seropositive to the Elitest with protein G or com-
mercial secondary antibody conjugates. In contrast, 2 red 
deer that were seronegative to the peptide ELISA were 
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Figure 2 Peptide ELISA. Absorbance distribution (Abs405nm) of 
seropositive red deer (n = 11) obtained with individual peptides 
98 M, 126M2 and 126M1 derived from Env protein of SRLV.
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seropositive with the modified Chekit test using EG5 
conjugate.
Seropositive deer were mainly found (15 out of 20 sero-
positive deer) in commercial farms which represents the 
largest sample source, followed by hunting campaigns 
with 4 seropositive animals. Seropositive roe deer were 
from hunts and the seropositive mouflon was from a zoo.
Seropositive animals were tested for the presence of 
neutralizing antibodies obtaining titres ranging from 3 to 
40.
Screening PCRs
Some bands of the expected size were obtained fol-
lowing PCR amplification using different sets of prim-
ers (Table  1). However, after purification, cloning and 
sequencing none corresponded to known SRLV provi-
ral sequences, instead they matched bovine genomic 
sequences. Therefore, PCRs for the bovine immunode-
ficiency virus (BIV) were performed in DNA samples 
from seropositive and seronegative deer, but none of the 
amplified products presented a lentiviral-type sequence, 
they were all identified as genomic DNA.
In vitro infection and entry assay
After being unable to demonstrate virus presence in wild 
ruminants by PCR in vivo, we decided to shift to in vitro 
experimental infection and transduction experiments. 
For this, as indicated in the particular experiments, DSF, 
FSF and BDM cultures were obtained and infected with 
SRLV strains belonging to genotype A (Ev1 and Swiss A4) 
or genotype B (CAEV-Co and Ov496). After 16  h, CPE 
was evident in cells from both species (red deer and fal-
low deer) only in the case of Ev1 virus. Since this effect 
may correspond to a virus over load, viral stocks were 
titrated again and infection was repeated with similar 
results.
To clarify if these results correspond to a differential 
ability of SRLV in entering the cell, entry assays using 
CAEV-AP virions pseudotyped with envelopes from dif-
ferent SRLV strains were carried out. Although all the 
tested strains were able to enter into red deer and fal-
low deer cells, there were differences among them. Red 
deer cells were more susceptible to Seui, Ev1 and CAEV-
Co strains in that order, while FSF mainly allowed the 
entrance of Ev1 strain from genotype A. Strains Roccav-
erano, and to a lesser extend 697, showed the lowest val-
ues in both cell types (Figure 3).
Post entry restriction
Once demonstrated the SRLV ability to enter into red 
deer and fallow deer cells, we checked further steps of 
the viral cycle such as integration and RNA produc-
tion. PCR at 16  h post-inoculation showed positive 
results in all cases confirming, the permissive entry and 
the presence of viral DNA within red deer and fallow 
deer cells. Regardless of the high transcriptional activ-
ity of the LTR in fibroblastic cells from deer and fallow 
deer (Figure  4), RNA production was confirmed only 
in the case of Ev1 infection in red deer cells 48 h after 
inoculation.
In spite of these positive correlates of lentiviral pro-
ductive infection, RT activity in the supernatants was 
negative in all cases at 7 and 10  days, suggesting low 
or no production of viral particles to the supernatants 
(Figures  5A and B). In order to check whether Ev1 and 
496 viruses were completely absent from DSF and FSF 
supernatants, we transferred them to fresh ovine fibro-
blasts. After 7 days, RT activity from both viruses started 
to increase only in the case of DSF, reaching positive 
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Figure 3 Entry assay with pseudotyped SRLV. Infectivity of 
CAEV‑AP virions pseudotyped with Env proteins from Ev1, CAEV‑Cork, 
Roccaverano, Seui and 697 SRLV strains on red deer skin fibroblasts 
(DSF) and fallow deer skin fibroblasts (FSF). Results are expressed as 
focus‑forming units per milliliter (FFU/mL).
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Figure 4 LTR promoter activity. LTR‑U3‑R region of SRLV strains 
CAEV‑Co, A4, Kv1772 and Ov496 transfected in goat synovial mem‑
brane cells (GSM), red deer skin fibroblasts (DSF) and fallow deer skin 
fibroblasts (FSF). Results are expressed as the ratio between the rela‑
tive firefly luminescence (RLU) and the Renilla luminescence.
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control values at the second supernatant transfer in OSF 
(Figures 5C and D).
In the case of strains A4 and CAEV-Co, viral RNA was 
detectable in the supernatants 7 days post-inoculation only 
in CAEV-Co infected cells. As above, supernatants from 
these infected-cells were used to infect GSM cells. After 
7 days, viral RNA increased in the supernatant for CAEV-Co 
strain but remained undetectable for A4 strain (Figure 5E).
Furthermore, infected DSF and FSF were passed weekly 
by trypsinization and after the first passage strains Ev1, 
496 and CAEV-Co showed increased production only 
in DSF, being the strain A4 not able to replicate. At the 
second passage, Ev1 was able to destroy the cellular mon-
olayer whereas strain 496 was adapted to DSF causing 
persistent infection similar to ovine fibroblasts. Virus 
production after passages in FSF remained always nega-
tive (Figure 6).
Production of GAG and ENV viral proteins was evalu-
ated by western-blot using monoclonal antibodies anti-
p25 and polyclonal sera from infected sheep, aiming at 
improving cross-reactivity. In agreement with RT activ-
ity, capsid protein production was detected in red deer 
cells infected with strains Ev1 and 496 at the second pas-
sage, and in OSF after inoculation with culture super-
natant from infected DSF. Also in agreement was the 
absence of capsid protein in FSF cells neither with 496 
nor Ev1 SRLV strains (Figure 7). Env protein was not spe-
cifically detected with the antisera used.
Red deer BDM allowed Swiss A4 infection but few 
viral RNA copies were amplified from the supernatant. 
Instead, CAEV-Co replicated more efficiently reach-
ing values obtained with ovine BDM. Fallow deer BDMs 
showed a more restricted phenotype, similar to that 
observed in skin fibroblasts showing undetectable virus 
production. Sheep BDM differentially allowed the repli-
cation of SRLV A4 and CAEV-Co strains. While A4 repli-
cated at high titres, CAEV-Co RNA was produced at low 
levels in the supernatant, confirming the impaired repli-
cation of this virus in ovine cells (data not shown).
Discussion
The emergence of the devastating HIV epidemics in the 
human population following cross species transmission 
from the natural non-human primate host, in which 
these lentiviruses cause non-pathogenic persistent infec-
tions [48], highlights the ability of this group of viruses 
to cross the species barrier, adapt to a new host and dra-
matically increase their virulence.
Transgression of the species-specific barrier by SRLV 
has been explored in cattle through experimental infec-
tion of cows with CAEV-Co strain [49]. SRLV infection 
induced a persistent antibody production, similar to 
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Figure 5 SRLV in vitro infection upon supernatant transfer. A RT activity (Abs405nm) of culture supernatants from red deer skin fibroblasts 
(DSF), fallow deer skin fibroblasts (FSF) and ovine fibroblasts (OSF) infected with SRLV strains Ev1 or 496. B Viral quantification of viral RNA (copies/
µL) in the supernatants from DSF, FSF and goat synovial membrane cells (GSM) infected with strains A4 or CAEV‑Co. C, D Culture supernatants from 
DSF, FSF and OSF infected with Ev1 or 496 respectively (P0) were transferred to fresh OSF twice (P1.OSF and P2.OSF) and RT values represented 
(Abs405nm). E SRLV RNA copies in the supernatant of DSF, FSF and GSM infected with CAEV‑Co (P0) and after transfer of supernatants to fresh GSM 
twice (P1.GSM and P2.GSM). Squares represent values from infected cells and circles indicate non‑infected cells.
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that observed in sheep or goats, suggesting viral protein 
production. However, this was not accompanied by pro-
ductive long-term infection; indeed although authors 
demonstrated proviral integration into leukocytes and 
tissues, infection did not persist more than 4 months, and 
virus was not recovered even after attempts to reactivate 
viral replication. Virus clearance was unlikely due to the 
humoral response, since antibodies were not neutralizing.
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Figure 6 SRLV in vitro infection upon culture passages. RT activity in the supernatant from red deer (DSF), fallow deer (FSF) and ovine fibro‑
blasts (OSF) infected with strains Ev1 (A) or 496 (B). C Viral quantification of total viral RNA (copies/µL) in the supernatants from DSF, FSF and goat 
synovial membrane (GSM) cells infected with strain CAEV‑Co. Squares represent values from infected cells and circles indicate non‑infected cells. 
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Figure 7 Production of P25 protein in cell culture. Western Blot of ovine fibroblasts (OSF) infected with supernatants from red deer (DSF), 
fallow deer (FSF) and OSF infected with strains Ev1 (A) or 496 (B) after 7 days of infection. Uninfected cells and recombinant p25 protein were also 
included as negative and positive controls respectively. Sera from two experimentally infected sheep with SRLV strains from genotype A and B 
respectively, were used to reveal protein production. Beta tubulin antibody was used as loading control.
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Here, we show positive serological reaction against dif-
ferent SRLV antigen preparations in red deer, roe deer 
and mouflon, being fallow deer negative. However, this 
serological reaction was not accompanied by the detec-
tion of SRLV sequences by PCR in vivo. In vitro, skin cell 
cultures from red deer and fallow deer did not produce 
detectable levels of SRLV Gag or RT proteins in spite of 
the presence of syncytia and viral DNA and RNA. Infec-
tion was rescued by transferring supernatants from red 
deer skin fibroblasts infected in  vitro, to fully permissive 
ovine fibroblasts suggesting the production of low levels of 
virus. Although highly dependent on the infecting strain, 
virus adaptation could be induced in DSF through periodi-
cal cell passages in vitro. In contrast, fallow deer cells did 
not support SRLV infection despite supernatant transfer 
or cell passages in agreement with serological findings. 
These results may suggest that SRLV are at different steps 
in the viral adaptation to red deer and fallow deer. In the 
last case, host may have evolved to mount an effective 
long-lasting restriction mechanism of lentiviral replication 
in  vivo. Neutralizing antibodies were detected in ELISA 
positive sera from red deer however, they unlikely play an 
important role in the viral infection restrictive pathway as 
described in caprine and ovine species [21, 50]. Serologi-
cal reaction was mostly detected by home-made ELISA in 
comparison with commercial tests as described for ovine 
and caprine infections likely due to the inclusion of novel 
epitopes providing wider cross-reactivity [39, 51]. Reaction 
was mainly directed against peptides 126M1 and 126M2 
suggesting a potential SRLV infection involving multi-
ple genotypes. Synthetic peptide ELISA performance was 
better using secondary antibody than protein G whose 
specificity against IgG from sheep and goats is moder-
ate and unknown in red deer [52]. Contact with sheep or 
goats cannot be excluded in animals coming from hunts or 
national parks, however seropositive animals were mainly 
found in commercial farms and zoos in which these con-
tacts are at present highly restricted.
Intra-individual SRLV viral reservoir is represented by 
proviral integration into monocytes that after matura-
tion to tissue macrophages become permissive to viral 
replication. Wild ruminants could act as inter-individual 
reservoir potentially responsible for the re-emergence 
of infection in domestic small ruminant flocks [32]. The 
high SRLV genome plasticity is translated into a wide 
tropism that allows the generation of immune escape 
mutants and the colonization of new target cells and 
hosts [53]. Accordingly, cells from humans, monkey, 
hamster, mice, quail, cows [49, 54, 55] and, as shown in 
this study, red deer and fallow deer are permissive to 
SRLV entry since viral DNA was detected in vitro upon 
infection of DSF and FSF. Consequently, amplification 
and adaptation to a broad spectrum of host species could 
be expected. Indeed, SRLV are causing natural cross-spe-
cies infection in wild ruminants following contact during 
the free grassing season in wilderness areas, potentially 
generating uncontrollable reservoir of viruses [32]. This 
could eventually represent a major obstacle in SRLV 
eradication programs in domestic sheep and goat flocks.
Endogenous retroviruses from cervids (CERVs) have 
been described in Mule deer (Odocoileus hemionus) 
genome [56], confirming previous contacts with retrovi-
ruses. Strong humoral and T cell responses are elicited 
against human retroviruses, especially to HERV-K10 in 
healthy but mostly in cancer patients due to higher viral 
expression [57, 58]. However, small ruminants do not 
mount a strong humoral or cellular immune response 
against exogenous JSRV, likely due to the presence of a 
related endogenous counterpart that induce tolerance 
[59]. Interestingly, sequences from CERV gag region were 
compared with VMV-like isolates and preliminary analy-
ses indicate some degree of structural similarity between 
both sets of sequences that might explain the presence of 
serological reaction in the absence of an exogenous len-
tivirus in vivo. Unfortunately, it is unknown whether red 
deer develop a detectable antibody production against 
CERV.
Antigenic cross-reactivity with CAEV in humans has 
been reported likely due to the consumption of contami-
nated caprine dairy products [60] potentially favoring 
SRLV adaptation to humans. In fact, numerous emerging 
infectious diseases including zoonosis have been origi-
nated from wildlife [1, 61]. Domestic animals have been 
selected for centuries towards a specific production (milk, 
meat, wool, etc.) and have not been subjected to the same 
natural selection pressure as their wildlife counterparts 
and as a result, they are less resistant to a high number of 
pathogens [62]. However, repeated contacts of potentially 
susceptible wildlife with domestic SRLVs may lead to the 
emergence of new adapted lentivirus variants [32].
Lack of viral proteins in cultured cells from wild rumi-
nants could be a consequence of the abnormal processing 
of the Env protein in these cell types. This has been pre-
viously described in sheep choroid plexus cells infected 
with CAEV-like virus [63]. However, if this was the 
case no CPE would be expected in DSF cells. Moreover, 
in  vitro findings in this study clearly show the presence 
of newly synthesized infectious particles in DSF and the 
ability of SRLV to adapt rapidly to cells from wild rumi-
nants in  vitro. However, since in  vivo lentivirus cross-
species transmission is a rare event that only occurs 
under specific circumstances other factors related to the 
host immune response may hamper the progression of 
infection.
The host innate immunity may play an important role 
in counteracting infection independent of the presence of 
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antibodies which are generated following antigenic pres-
entation in the presence or absence of viral replication. 
Remarkably, cell factors involved in innate and adaptive 
immunity may evolve much quicker than those required 
for cell survival likely contributing to lentiviral resistance. 
Intracellular restriction mechanisms described in small 
ruminants include tripartite motif containing (TRIM5α) 
and APOBEC3, both leading to proteasomal degrada-
tion of viral proteins and therefore sharing the MHC-I 
antigenic presentation pathway that could result in anti-
body production in the absence of viral replication. On 
the other hand, tetherin, which impedes normal virus 
burden at final steps of the infection cycle, may interfere 
virus release without affecting proviral load or RNA tran-
scripts. Therefore a future study on SRLV restriction due 
to intrinsic factors from wild ruminants is warranted.
In summary, our results suggest that cells from the 
Cervidae family are susceptible to SRLV infection in vitro 
but factors involved at post-entry steps are controlling 
infection spread in vivo. These results may indicate that 
cervids have a bystander role in SRLV epidemiology.
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